312 records found.
Aug 13, 2019
AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio
Aug 07, 2019
REGENXBIO Reports Second Quarter 2019 Financial and Operating Results and Additional Positive Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD
Aug 07, 2019
Global $1.01 Billion Cell and Gene Therapy Market 2019-2025: Steady Investment and Consolidation in the Market
Aug 06, 2019
The cell and gene therapy Industry analysis by BIS Research projects the market to grow at a significant CAGR of 36.52% during the forecast period, 2019-2025
Aug 01, 2019
The T-cell Immunotherapies Market is Projected to Reach USD 26 Billion by 2030, Growing at an Annualized Rate of 41.5%, Claims Roots Analysis
Jul 31, 2019
Cell Therapy Companies, Technologies, Markets, 2028
Jul 29, 2019
Global Gene Therapy Markets, 2013-2018 & 2019 & 2025
Jul 24, 2019
REGENXBIO and Neurimmune Announce Collaboration to Develop Vectorized Antibodies for the Treatment of Neurodegenerative Diseases
Jul 21, 2019
Personalized gene-edited immune cell therapy for patients with solid cancers: New data establishes approach for verifying patient-specific cancer mutation targets
Jul 16, 2019
GEMoaB Announces the Appointment of Oncology Expert Michael Pehl as Chief Executive Officer
Jul 08, 2019
BioMarin Plans Regulatory Submissions for Marketing Authorization of Valoctocogene Roxaparvovec to Treat Severe Hemophilia A in 4Q 2019 in both U.S. and Europe
Jul 05, 2019
ISTH Announces Launch Of New Global Education Initiative In Gene Therapy For Hemophilia
Jun 26, 2019
Kymriah (tisagenlecleucel; Novartis) Drug Profile 2019: A Cluster of Differentiation (CD)19-Targeted Genetically Modified Autologous T-cell Immunotherapy
Jun 26, 2019
BioMarin Announces Acceptance of Late Breaking Abstract at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress in Melbourne, Australia from July 6-10, 2019
Jun 26, 2019
Encoded Therapeutics, Inc. Announces $104 Million Series C Financing to Advance Lead Gene Therapy Program in Dravet Syndrome and Unveils its Precision Gene Therapy Platform
Jun 21, 2019
Sangamo Announces Upcoming Presentation Of Investigational SB-525 Hemophilia A Gene Therapy Data At ISTH 2019
Jun 21, 2019
FDA expands approval of treatment for cystic fibrosis to include patients ages 6 and older
Jun 20, 2019
Gracell Data on Multi-center Investigation of FasT CAR-19 Therapy Shows Positive First Impact in Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
Jun 20, 2019
Marker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA Therapy in Patients with Pancreatic Adenocarcinoma
Jun 19, 2019
CARsgen Therapeutics Receives IND Clearance for BCMA-CAR-T Cells from the U.S. FDA

Pages